The Global Renaissance in Psychedelic-Assisted Therapies
Dr. Daniel Kelly, a neurosurgeon who specializes in minimally invasive brain surgery and is recognized for advancing these techniques, will join the leaders behind Multidisciplinary Association for Psychedelic Studies (MAPS) in a discussion on psychedelics and their role in mental health. Kelly, who helped launch the Pacific Brain Health Center, has been a driving force behind the center’s Pacific Treatment & Research in Psychedelics (TRIP) program — a program not too different (although in its infancy) from the groundbreaking work being done by Julie Holland, Amy Emerson and Berra Yazar-Klosinski at MAPS.
Together, the scientists and medical professionals will explore why psychedelic-assisted therapies work, what roadblocks they face and what the future of therapy could look like.